Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-003823
Filing Date
2024-11-25
Accepted
2024-11-25 07:07:08
Documents
6
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 6-K zk2432387.htm 6-K 9695
2 REGISTRANT'S PRESS RELEASE DATED NOVEMBER 25, 2024. exhibit_1.htm EX-99 377977
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF SEPTEMBER exhibit_2.htm EX-99 484522
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF SEPTEMBER 30, 2024 AND FOR THE exhibit_3.htm EX-99 270728
5 image00001.jpg GRAPHIC 27798
6 image00003.jpg GRAPHIC 60615
  Complete submission text file 0001178913-24-003823.txt   1266076
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 241491901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)